GALMED PHARMACEUTICALS LTD. Operating Loss Carryforwards
GALMED PHARMACEUTICALS LTD. (GLMD) had Operating Loss Carryforwards of $205.90 million as of 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Notes › Income Taxes
us-gaap:OperatingLossCarryforwards · last filed 2026-03-31
- 2025-12-31: Operating Loss Carryforwards $205.90M.
- 2024-12-31: Operating Loss Carryforwards $175.40M.
- 2023-12-31: Operating Loss Carryforwards $165.10M.
- 2022-12-31: Operating Loss Carryforwards $152.20M.
| Period end | Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $205.90M 20-F · filed 2026-03-31 |
| 2024-12-31 | $175.40M 20-F · filed 2025-04-02 |
| 2023-12-31 | $165.10M 20-F · filed 2024-04-04 |
| 2022-12-31 | $152.20M 20-F · filed 2023-03-29 |
| 2021-12-31 | $137.90M 20-F · filed 2022-05-02 |
| 2020-12-31 | $110.90M 20-F · filed 2021-03-18 |
| 2019-12-31 | $95.70M 20-F · filed 2020-03-12 |
| 2018-12-31 | $63.90M 20-F · filed 2019-03-13 |
| 2017-12-31 | $52.50M 20-F · filed 2018-03-13 |
| 2016-12-31 | $36.00M 20-F · filed 2017-03-23 |
| 2015-12-31 | $24.20M 20-F · filed 2016-03-22 |
| 2014-12-31 | $20.70M 20-F · filed 2015-03-31 |